Public-facing science lineage platform

The scientific lineage behind human disease breakthroughs

TrialLineage traces drugs, clinical trials, and medical advances back through the basic science, enabling methods, translational work, and research communities that made them possible.

Why this exists

Most medical breakthroughs are presented as isolated events. In reality, they emerge from decades of interrelated inquiry: molecular biology, disease modeling, chemistry, clinical translation, failed paths, and enabling tools.

TrialLineage is designed to make that hidden structure visible in plain language, while preserving scientific seriousness and room for deeper exploration.

How it works

A layered explanation system, not just a news summary

1. Breakthrough

Start with a drug, trial, or clinical development that matters now in human disease.

2. Reverse lineage

Trace backward through disease biology, enabling methods, chemistry, and prior discoveries.

3. Offshoots

Open linked explainers for related fields so the main page stays readable while deeper understanding remains available.

4. Ongoing updates

Evolving pages can later support monitored updates, new trial milestones, and expanding concept connections.

Core concept areas

The interrelated fields behind one breakthrough

One case can connect multiple scientific domains. These linked concept areas will become reusable explainer pages across the platform.

Oncogene discovery
Protein signaling biology
Pancreatic precursor lesion biology
Chemical biology
Medicinal chemistry
Structural biology
Translational oncology
Clinical trial design

Early build

The first version of TrialLineage is being built as a public-facing lineage system for human disease breakthroughs, with room for deeper case pages, reusable concept explainers, and a future production layer that supports careful updates over time.